Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
OpGen, Inc. - Common Stock
(NQ:
OPGN
)
1.960
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about OpGen, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
OpGen Provides Preliminary Unaudited Revenue for FY 2022 and Business Update
January 18, 2023
From
OpGen, Inc.
Via
GlobeNewswire
OpGen Subsidiary Curetis Meets Several Key Milestones in FIND Collaboration Project
January 17, 2023
Successful delivery of milestones triggers milestone payment
From
OpGen, Inc.
Via
GlobeNewswire
OpGen Announces Closing of $7.5 Million Public Offering
January 11, 2023
From
OpGen, Inc.
Via
GlobeNewswire
OpGen Announces Pricing of $7.5 Million Public Offering
January 06, 2023
From
OpGen, Inc.
Via
GlobeNewswire
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
January 05, 2023
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
January 04, 2023
Via
Benzinga
OpGen Announced 1-for-20 Reverse Stock Split
January 04, 2023
From
OpGen, Inc.
Via
GlobeNewswire
Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket
↗
December 20, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small...
Via
Benzinga
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
↗
December 29, 2022
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.
Via
Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
↗
December 19, 2022
Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
December 14, 2022
Via
Benzinga
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
↗
December 14, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
December 14, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 14, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
December 14, 2022
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about on Wednesday!
Via
InvestorPlace
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
↗
December 14, 2022
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.
Via
Benzinga
Nasdaq Rises 100 Points; Gold Gains Over 1%
↗
December 13, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining 100 points on Tuesday
Via
Benzinga
ARBK Stock Alert: Will Argo Blockchain Go Bankrupt?
↗
December 13, 2022
Argo Blockchain (ARBK) stock is falling hard on Tuesday after the Bitcoin (BTC-USD) mining company warned of financial troubles.
Via
InvestorPlace
Why Is OpGen (OPGN) Stock Up 148% Today?
↗
December 13, 2022
OpGen (OPGN) stock is rocketing higher on Tuesday after posting results from its Unyvero urinary tract infections (UTI) clinical trial.
Via
InvestorPlace
Dow Turns Lower; Crude Oil Rises Sharply
↗
December 13, 2022
U.S. stocks pared gains midway through trading, with the Dow Jones turning lower on Tuesday
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
December 13, 2022
Via
Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
↗
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
OpGen (NASDAQ: OPGN) Reports Positive Data from Clinical Trial for Unyvero as Diagnostic for UTI
December 13, 2022
OpGen, Inc. (NASDAQ: OPGN) is engaged as a precision medicine company that is focused on developing molecular diagnostics and bioinformatics
Via
Spotlight Growth
Penny Stock OpGen Surges After UTI Panel Test Meets Primary Goal In Clinical Trial
↗
December 13, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
December 13, 2022
Via
Benzinga
OpGen Announces Positive Top Line Data from Clinical Trial for Unyvero Urinary Tract Infection Panel
December 13, 2022
From
OpGen, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 28, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
November 24, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 24, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
November 23, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
